HLA-DQ relative risks for coeliac disease in European populations: A study of the European Genetics Cluster on Coeliac Disease

Tissue Antigens

Volumn 63, Issue 6, 2004, Pages 562-567

  Margaritte Jeannin, P ^a,f   Babron, M C ^a   Bourgey, M ^a   Louka, A S ^b   Clot, F ^a,c   Percopo, S ^d   Coto, I ^d   Hugot, J P ^c   Ascher, H ^e   Sollid, L M ^b   Greco, L ^d   Clerget Darpoux, F ^a  

^a INSERM   (France)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c FONDATION JEAN DAUSSET CEPH   (France)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^f HÔPITAL PAUL BROUSSE   (France)

Author keywords

Coeliac disease; HLA heterodimer; MHC class II; Relative risk

Indexed keywords

HLA ANTIGEN CLASS 1;

ARTICLE; CELIAC DISEASE; EUROPE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; MAXIMUM LIKELIHOOD METHOD; PRIORITY JOURNAL;

CELIAC DISEASE; EUROPE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-DQ ANTIGENS; RISK;

EID: 2942512905     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-2815.2004.00237.x     Document Type: Article

References (27)

1. Trier JS. Coeliac sprue. N Engl J Med 1991: 325: 1709-19.
2. Falchuk ZM, Rogentine N, Strober W. Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy. J Clin Invest 1972: 51: 1602-5.
3. De Marchi M, Borelli I, Olivetti E et al. Two HLA-DR alleles are associated with coeliac disease. Tissue Antigens 1979: 14: 309-16.
4. Tosi R, Vismara D, Tanigaki N et al. Evidence that coeliac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol 1983: 28: 395-404.
5. Sollid LM, Markussen G, Ek J et al. Evidence for a primary association of coeliac disease to a particular HLA-DQ α/β heterodimer. J Exp Med 1989: 169: 345-50.
6. Sollid LM, Thorsby E. The primary association of coeliac disease to a given HLA-DQa/b heterodimer explains the divergent HLA-DR association observed in various Caucasian population. Tissue Antigens 1990: 36: 136-7.
7. Ploski R, Ek J, Thorsby E, Sollid LM. On the HLA-DQ (α*0501, β*0201) associated susceptibility in coeliac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 1993: 41: 173-7.
8. Clerget-Darpoux F, Bouguerra F, Kastally R et al. High risk genotypes for coeliac disease. C R Acad Sci Paris III 1994: 317: 931-6.
9. Vader W, Stepniak D, Kooy Y et al. The HLA-DQ2 gene dose effect in coeliac disease is directly related to the magnitude and breadth of the gluten-specific T cell responses. Proc Natl Acad Sci USA 2003: 100: 12390-5.
10. Sollid LM, Thorsby E. HLA susceptibility genes in coeliac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993: 105: 910-22.
11. Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 2003: 61: 105-17.
12. Karell K, Louka AS, Moodie SJ et al. HLA types in coeliac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Coeliac disease. Hum Immunol 2003: 64: 469-77.
13. Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of coeliac disease. Report of the Working Group of the European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990: 65: 909-11.
14. Charron D, ed. HLA. Genetic Diversity of HLA: Functional and Medical Implication. Paris: EDK, 1997.
15. Louka AS, Nilsson S, Olsson M et al. HLA in coeliac disease families: a novel test of risk modification by the other haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens 2002: 60: 147-54.
16. Bouguerra F, Babron MC, Eliaou JF et al. Synergistic effect of two HLA heterodimers in the susceptibility to coeliac disease in Tunisia. Genet Epidemiol 1997: 14: 413-22.
17. Clerget-Darpoux F, Babron MC, Bouguerra F et al. Synergistic effect of two HLA heterodimers in coeliac disease. In: Charron D, ed. Genetic Diversity of HLA. Functional and Medical Implications, Vol. 2. Paris, France: EDK Press, 1997: 718-9.
18. Thomson G. Mapping disease genes: family based association studies. Am J Hum Genet 1995: 57: 487-98.
19. Djilali-Saiah I, Caillat-Zucman S, Schmitz J et al. Polymorphism of antigen processing (TAP, LMP) and HLA class II genes in coeliac disease. Hum Immunol 1994: 40: 8-16.
20. Demarchi M, Borelli I, Olivetti E et al. Two HLA-D and DR alleles are associated with coeliac disease. Tissue Antigens 1979: 14: 309-16.
21. Polvi A, Maki M, Partanen J. Coeliac patients predominantly inherit HLA-DPB1*0101 positive haplotype from HLA-DQ2 homozygous parent. Hum Immunol 1997: 53: 156-8.
22. McManus R, Moloney M, Borton M et al. Association of coeliac disease with microsatellite polymorphisms close to the tumor necrosis factor genes. Hum Immunol 1996: 45: 24-31.
23. Louka AS, Lie BA, Talseth B et al. Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles. Immunogenetics 2003: 55: 339-43.
24. Fernandez L, Fernandez-Arquero M, Gual L et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene in coeliac disease. Tissue Antigens 2002: 59: 219-22.
25. Bolognesi E, Karell K, Percopo S et al. An additional factor in some HLA DR3/DQ2 haplotypes confers a four fold increased genetic risk of coeliac disease. Tissue Antigens 2003: 61: 308-16.
26. Lie BA, Sollid LM, Ascher H et al. A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabtes and coeliac disease. Tissue Antigens 1999: 54: 162-8.
27. Louka AS, Moodie SJ, Karell K et al. A collaborative European search for non-DQA1*05-DQB1*02 coeliac disease loci on HLA-DR3 haplotypes: analysis of transmission from homozygous parents. Hum Immunol 2003: 64: 350-8.